You are here: Industry Insights > GlaxoSmithKline

News List

AstraZeneca's Bevespi Aerosphere fails to outperform GlaxoSmithKline's Anoro Ellipta in COPD trial firstwordpharma
August 24, 2018
AstraZeneca on Thursday announced top-line results from a Phase IIIb study of patients with moderate to very severe chronic obstructive pulmonary disease (COPD).......
GlaxoSmithKline seeking bids for Indian consumer healthcare business: report firstwordpharma
August 22, 2018
According to people familiar with the matter, GlaxoSmithKline has sent out an information memorandum with preliminary details about its Indian consumer healthcare business to potential suitors and is seeking bids for the unit by the middle of next month
GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in Ireland fiercepharma
August 17, 2018
The future of GlaxoSmithKline’s Sligo plant in Ireland has been uncertain for many years. Now it’s settled: The U.K. company will close the plant and lay off its 165 workers over the next three years.
GlaxoSmithKline, Seqirus launch first round of flu shots for upcoming season fiercepharma
August 15, 2018
As flu-vaccine heavyweights dispatch their first doses for the upcoming season, they're planning millions more doses made with next-generation production processes, rather than traditional egg-based manufacturing.
GlaxoSmithKline chief recruits new CFO Iain Mackay to spearhead cost-cutting effort fiercepharma
August 08, 2018
With GlaxoSmithKline CFO Simon Dingemans on his way out, the pharma giant needed someone to push through its newly announced restructuring plan. And CEO Emma Walmsley has made her choice.
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech fiercebiotech
August 02, 2018
Novartis has penned a pact with Shanghai-based biotech Laekna that will see it work on a pair of oral pan-Akt kinase inhibitors.
GlaxoSmithKline closes Bangladesh manufacturing, cuts 1,000 workers fiercepharma
July 31, 2018
GlaxoSmithKline has been remaking its emerging markets operations to be more efficient and cost effective and a manufacturing plant and 1,000 employees in Bangladesh are the next to be streamlined into extinction.
GlaxoSmithKline's Shingrix beats expectations again in Q2 despite supply constraint fiercepharma
July 30, 2018
GlaxoSmithKline's hot shingles vaccine Shingrix has routinely beaten expectations since its U.S. rollout, and its second-quarter performance was no different.
GlaxoSmithKline's Nucala hopes take a hit with FDA panel thumbs-down in COPD fiercepharma
July 27, 2018
As would-be rivals struggled with winning FDA approvals in the last few years, GlaxoSmithKline's key respiratory franchise has reaped the benefit. But now, the company is suffering a setback of its own.
Forget a consumer spinoff. GlaxoSmithKline is plotting a $525M cost-cutting drive instead fiercepharma
July 26, 2018
GlaxoSmithKline is sticking with its three-unit structure, CEO Emma Walmsley told investors Wednesday.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page